Nucleome Therapeutics
Biotechnology company decoding the dark matter of the human genome
Oxford, UKwww.nucleome.com ↗
Total raised
€38M
€38,189,045
Funding rounds
1
Investors
5
distinct backers
Active since
2022-10
latest 2022-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-19 | Series A | €38M | British PatientCapital,Johnson & Johnson Innovation – JJDC,M Ventures,Oxford Science Enterprises,Pfizer Ventures | View deal → |
Investors
5Related news
- Nucleome Therapeutics Raises £37.5M in Series A Financingfinsmes.com · 2022-10